CRITERIA FOR SELECTION
In their evaluation, the Committee will consider the following criteria:
Criterion 1: Evaluation of the Applicant
- Potential for a career in hematology/oncology related research, with a focus on hematologic malignancies
- Academic record
- Prior research experience and/or publications in hematology/oncology related research
Criterion 2: Mentor/Training Plan and Scientific Environment
- Letter of support from mentor which includes: commitment to supporting the continued career trajectory of the applicant within the institution, mentor’s track record of productivity, funding and success with prior trainees, detailed description of the mentoring plan, including available resources allocated to the proposed research project, provision of protected time and available laboratory facilities
- The mentor is a well-established scientist whose research accomplishments have resulted in the bestowal of “tenure,” i.e., long-term commitment of salary, personnel, and research resources
- The mentor has the experience to direct the proposed research training, as evidenced by the letter of support
- The training plan is sufficient to facilitate the applicant’s progress towards his/her research career goals
- The proposed scientific environment contributes to the probability of success for the training experience
- Letter of support from the department chair or division chief that documents the institution is willing and has the ability to commit the resources necessary for the applicant to complete the proposed research, including sufficient protected time.
- The department chair or division chief should also outline their commitment for supporting the continued career trajectory of the applicant at the institution following the completion of the award period
Criterion 3: Evaluation of the Proposal
- Innovation and Significance: The research proposal is new and original and addresses an important question/issue related to hematology/oncology. The proposed study will have an effect on concepts, methods, and/or technologies related to hematology/oncology research, with a focus on hematologic malignancies
- Approach: The conceptual framework, design, methods, and analyses are adequately developed, well-integrated, well-reasoned, feasible (as determined by preliminary data or the expertise available), and appropriate to the aims of the project. The applicant acknowledges potential problem areas and considers alternative tactics
- Feasibility: The project, as described in the submitted proposal and budget, can be accomplished within the timeframe of the award
- © 2020 Gilead Sciences, Inc. All rights reserved. GILEAD and the GILEAD logo are
- registered trademarks of Gilead Sciences, Inc., or one of its related companies. Kite
- and the Kite Logo are registered trademarks of Kite, a Gilead company.
- © 2020 Gilead Sciences, Inc. All rights reserved.
- Job code: IHQ-ONC-2020-11-0012
- Date of prep: December 2020